Abstract: The invention provides a vaccine comprising an effective amount of an isolated recombinant influenza virus comprising a mutant M gene segment that is mutated so that upon viral replication the mutant M gene expresses a functional M1 protein and a mutant M2 protein with a deletion of the cytoplasmic tail and either lacking a transmembrane domain or having a mutated transmembrane domain.

Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.

Abstract: A printing apparatus capable of executing printing based on a flat-rate use service, the printing apparatus includes: a first connection unit for first connection which is between a printing apparatus and a first apparatus and for which a first method is used; a second connection unit for second connection which is between the printing apparatus and a second apparatus and for which a second method is used; a detection unit which detects that the second connection has been established; and a control unit which causes the printing apparatus to operate in a predetermined mode for performing setting for establishing the first connection. Even if it is detected while the printing apparatus is operating in the predetermined mode that the second connection has been established, the control unit causes the printing apparatus to continue operation in the predetermined mode.

Abstract: The present invention provides cells which have a high ability to propagate influenza virus, are suitable for use in production of an influenza virus for preparing a vaccine, and are able to be cultured in vitro, and a method for producing an influenza virus using the cells. That is, the present invention provides cells for producing an influenza virus in which expression of one or more genes that encode proteins involved in an effect of suppressing influenza virus production in a cell is suppressed and the gene is at least one selected from the group including ACTG1 gene and the like, and a method for producing an influenza virus that includes infecting the cells for producing an influenza virus with an influenza virus and then culturing.

Abstract: A setting information transmission apparatus includes a storage unit configured to store setting information for a previously-made initial setting for an external apparatus, a first reception unit configured to receive information about the external apparatus and initial setting start information from the external apparatus, and a transmission unit configured to transmit, upon receiving the initial setting start information, setting information for an initial setting to the external apparatus depending on the information about the external apparatus with reference to the setting information for the previously-made initial setting for the external apparatus.

Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.

Abstract: A communication apparatus includes a control unit that causes the communication apparatus to operate, based on that a predetermined command is received through a second connection in a first exclusive state in which the communication apparatus does not receive connection information through a first connection or a second exclusive state in which the communication apparatus is not connected to an external device corresponding to the connection information that is received through the first connection.

Abstract: A communication apparatus configured not to execute displaying, based on the operation in the connection setting state being started, a screen for receiving an operation for stopping the operation in the connection setting state on a display unit of the communication apparatus.

Abstract: The invention provides a vaccine comprising an effective amount of an isolated recombinant influenza virus comprising a mutant M gene segment that is mutated so that upon viral replication the mutant M gene expresses a functional M1 protein and a mutant M2 protein with a deletion of the cytoplasmic tail and either lacking a transmembrane domain or having a mutated transmembrane domain.

Abstract: The invention provides a vaccine comprising an effective amount of an isolated recombinant influenza virus comprising a mutant M gene segment that is mutated so that upon viral replication the mutant M gene expresses a functional M1 protein and a mutant M2 protein with a deletion of the cytoplasmic tail and either lacking a transmembrane domain or having a mutated transmembrane domain.

Abstract: The present invention is intended to provide an adjuvant having high safety to living bodies and an action to sufficiently reinforce immune function, and a vaccine comprising the adjuvant. Specifically, the present invention relates to 34 novel adjuvant candidate compounds, which have been identified by screening 145 food additives and 51 injection additives, using, as indicators, an increase in the antibody titer against influenza virus and a protective effect against infection with influenza virus, and then selecting those having the function of increasing the antiviral antibody titer in blood and the protective effect against viral infection. In addition, the present invention also relates to a vaccine comprising these adjuvant candidate compounds.

Abstract: A communication apparatus configured not to execute displaying, based on the operation in the connection setting state being started, a screen for receiving an operation for stopping the operation in the connection setting state on a display unit of the communication apparatus.

Abstract: A wireless communication apparatus comprises: a search unit that searches, by using a plurality of frequency bandwidths, for an access point to perform wireless communication; a display unit that displays, based on pieces of predetermined information corresponding to a plurality of access points detected by a search, display items corresponding to the pieces of predetermined information; and a processing unit that performs, when the display items are displayed and a user selects one of the display items, connection processing to an access point specified by the selection of the display item, wherein when a display item corresponding to a first access point and a second access point is selected, the processing unit performs the connection processing to an access point that satisfies a predetermined condition, among the first access point and the second access point.

Abstract: A communication apparatus includes a control unit that causes the communication apparatus to operate, based on that a predetermined command is received through a second connection in a first exclusive state in which the communication apparatus does not receive connection information through a first connection or a second exclusive state in which the communication apparatus is not connected to an external device corresponding to the connection information that is received through the first connection.

Abstract: The present invention provides cells which have a high ability to propagate influenza virus, are suitable for use in production of an influenza virus for preparing a vaccine, and are able to be cultured in vitro, and a method for producing an influenza virus using the cells. That is, the present invention provides cells for producing an influenza virus in which expression of one or more genes that encode proteins involved in an effect of suppressing influenza virus production in a cell is suppressed and the gene is at least one selected from the group including ACTG1 gene and the like, and a method for producing an influenza virus that includes infecting the cells for producing an influenza virus with an influenza virus and then culturing.

Abstract: A problem is solved by providing a communication apparatus including a displaying unit that displays, on a display unit, a predetermined screen for executing a second communication setting that allows the communication apparatus to communicate with a terminal apparatus by using a second communication method, which is different from a first communication method, in a case where a cancel instruction is received while the communication apparatus is operating in a predetermined condition.

Abstract: The present invention provides cells which have a high ability to propagate influenza virus, are suitable for use in production of an influenza virus for preparing a vaccine, and are able to be cultured in vitro, and a method for producing an influenza virus using the cells. That is, the present invention provides cells for producing an influenza virus in which expression of one or more genes that encode proteins involved in an effect of suppressing influenza virus production in a cell is suppressed and the gene is at least one selected from the group including ACTG1 gene and the like, and a method for producing an influenza virus that includes infecting the cells for producing an influenza virus with an influenza virus and then culturing.

Abstract: The invention provides a vaccine comprising an effective amount of an isolated recombinant influenza virus comprising a mutant M gene segment that is mutated so that upon viral replication the mutant M gene expresses a functional M1 protein and a mutant M2 protein with a deletion of the cytoplasmic tail and either lacking a transmembrane domain or having a mutated transmembrane domain.

Abstract: A print control apparatus enables a network setting to be changed during print preparation processing executed at the arrival, thereby enabling the user to bring start time to use the print control apparatus forward.

Abstract: A problem is solved by providing a communication apparatus including a displaying unit that displays, on a display unit, a predetermined screen for executing a second communication setting that allows the communication apparatus to communicate with a terminal apparatus by using a second communication method, which is different from a first communication method, in a case where a cancel instruction is received while the communication apparatus is operating in a predetermined condition.